Our findings show a significantly elevated expression of CNN2 in the serum of HCC patients, while no statistically significant difference was observed between the positive rate of CNN2 in the serum of other tumor patients and that of the healthy control group. The gene discussed is CNN2; the disease is hepatocellular carcinoma.